SoftBank Group’s Guardant Health GH Stock Holding History

SoftBank Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,033,990	Closed	-$76.5M	–	3
2018 Q4	$76.5M	Buy	+2,033,990	New	+$74.9M	0.38%	2

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $31.9B AUM 28.45% 1-Year Est. Return

VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SoftBank Group's GH Position: Q1 2019 in Review

SoftBank Group sold out of Guardant Health (GH) in Q1 2019, closing a stake of 2,033,990 shares — an estimated $76.5M sold.

SoftBank Group first reported a position in GH in Q4 2018 and held it in 1 quarter. The position peaked at $76.5M in Q4 2018. 150 funds tracked by Wall St. Rank hold GH as of Q1 2019.

SoftBank Group reported no remaining Guardant Health position as of Q1 2019 after selling out during the quarter.
SoftBank Group sold 2,033,990 Guardant Health shares in Q1 2019, an estimated $76.5M.
SoftBank Group first reported a position in Guardant Health in Q4 2018 and held it in 1 quarter.
SoftBank Group's Guardant Health position peaked at $76.5M in Q4 2018.
150 funds tracked by Wall St. Rank held Guardant Health as of Q1 2019.

Based on SoftBank Group's 13F filing for Q1 2019, filed 9 Oct 2020.